Faes Farma S.A [FAE] vs Labiana Health S.A [LAB] Detailed Stock Comparison

Faes Farma S.A.

BME
Loading...

Labiana Health S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Faes Farma S.A. wins in 7 metrics, Labiana Health S.A. wins in 12 metrics, with 0 ties. Labiana Health S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Faes Farma S.A. Labiana Health S.A. Better
P/E Ratio (TTM) 19.60 42.50 Faes Farma S.A.
Price-to-Book Ratio 2.05 7.81 Faes Farma S.A.
Debt-to-Equity Ratio 58.11 998.21 Faes Farma S.A.
PEG Ratio 14.10 6.04 Labiana Health S.A.
EV/EBITDA 16.41 7.09 Labiana Health S.A.
Profit Margin (TTM) 12.70% 1.26% Faes Farma S.A.
Operating Margin (TTM) 0.64% 13.02% Labiana Health S.A.
EBITDA Margin (TTM) 0.64% 13.02% Labiana Health S.A.
Return on Equity 10.82% 23.11% Labiana Health S.A.
Return on Assets (TTM) 5.06% 7.43% Labiana Health S.A.
Free Cash Flow (TTM) $54.85M $4.15M Faes Farma S.A.
Dividend Yield 4.09% N/A N/A
1-Year Return 15.38% 122.04% Labiana Health S.A.
Price-to-Sales Ratio (TTM) 2.43 0.60 Labiana Health S.A.
Enterprise Value $1.84B $66.57M Faes Farma S.A.
EV/Revenue Ratio 2.94 0.93 Labiana Health S.A.
Gross Profit Margin (TTM) 63.93% 147.79% Labiana Health S.A.
Revenue per Share (TTM) $2 $10 Labiana Health S.A.
Earnings per Share (Diluted) $0.25 $0.12 Faes Farma S.A.
Beta (Stock Volatility) 0.32 -0.30 Labiana Health S.A.

Faes Farma S.A. vs Labiana Health S.A. Stock Performance Analysis

Loading Price Chart...

FAE
LAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Faes Farma S.A.-1.23%-2.24%6.90%-6.07%6.90%-8.05%
Labiana Health S.A.16.38%37.20%27.36%54.11%60.71%37.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Faes Farma S.A.15.38%50.00%38.33%75.18%77.12%-48.94%
Labiana Health S.A.122.04%125.00%9,542.86%743.75%743.75%743.75%

Performance & Financial Health Analysis: Faes Farma S.A. vs Labiana Health S.A.

MetricFAELAB
Market Information
Market Cap i€1.51B€49.24M
Market Cap CategoryLarge capSmall cap
10 Day Avg. Volume i128,57410,525
90 Day Avg. Volume i149,17712,584
Last Close€4.80€6.75
52 Week Range€4.09 - €5.44€2.80 - €6.95
% from 52W High-11.76%-2.88%
All-Time High€19.40 (Feb 05, 2007)€6.95 (Apr 24, 2026)
% from All-Time High-75.26%-2.88%
Growth Metrics
Quarterly Revenue Growth0.48%0.12%
Quarterly Earnings Growth-0.81%0.55%
Financial Health
Profit Margin (TTM) i0.13%0.01%
Operating Margin (TTM) i0.01%0.13%
Return on Equity (TTM) i0.11%0.23%
Debt to Equity (MRQ) i58.11998.21
Cash & Liquidity
Book Value per Share (MRQ)€2.39€0.65
Cash per Share (MRQ)€0.42€0.54
Operating Cash Flow (TTM) i€78.49M€3.18M
Levered Free Cash Flow (TTM) i€17.98M€642,357
Dividends
Last 12-Month Dividend Yield i4.09%N/A
Last 12-Month Dividend i€0.22N/A

Valuation & Enterprise Metrics Analysis: Faes Farma S.A. vs Labiana Health S.A.

MetricFAE (Apr 24, 2026)LAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.6042.50
Forward P/E i14.106.04
PEG Ratio i14.106.04
Price to Sales (TTM) i2.430.60
Price to Book (MRQ) i2.057.81
Market Capitalization
Market Capitalization i€1.51B€49.24M
Enterprise Value i€1.84B€66.57M
Enterprise Value Metrics
Enterprise to Revenue i2.940.93
Enterprise to EBITDA i16.417.09
Risk & Other Metrics
Beta i0.32-0.30
Book Value per Share (MRQ) i€2.39€0.65

Financial Statements Comparison: Faes Farma S.A. vs Labiana Health S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFAE (2025)LAB (2024)
Revenue/Sales i610.46M66.26M
Cost of Goods Sold i214.55M25.31M
COGS % of Revenue i35.1%38.2%
Gross Profit i395.91M40.94M
Gross Margin i64.9%61.8%
Research & Development iN/AN/A
Operating Income (EBIT) i88.83M5.10M
Operating Margin i14.6%7.7%
EBITDA i119.87M9.31M
EBITDA Margin i19.6%14.0%
Pre-Tax Income i85.41M-29,997
Pre-Tax Income % of Revenue i14.0%0.0%
Income Tax i5.75M-236,502
Income Tax % of Revenue i0.9%-0.4%
Net Income (Profit) i79.66M206,505
Profit Margin i13.0%0.3%

Balance Sheet & Liquidity Metrics

MetricFAE (2025)LAB (2024)
Cash & Equivalents i117.31M6.74M
Total Current Assets i482.40M28.70M
Total Current Assets % of Revenue i79.0%43.3%
Total Current Liabilities i184.88M22.16M
Total Current Liabilities % of Revenue i30.3%33.4%
Long-Term Debt i373.73M27.24M
Long-Term Debt % of Revenue i61.2%41.1%
Total Shareholders Equity i745.59M2.57M
Retained Earnings i194.59M253,449
Retained Earnings % of Revenue i31.9%0.4%
Property, Plant & Equipment i353.31M1.27M

Cash Flow Statement Comparison

MetricFAE (2025)LAB (2024)
Operating Cash Flow i96.58M5.46M
Operating Cash Flow % of Revenue i15.8%8.2%
Capital Expenditures i-21.46M-3.01M
Free Cash Flow i54.85M4.15M
FCF Margin i9.0%6.3%
Debt Repayment iN/A-3.64M
Common Stock Repurchase iN/A-158,929

Short Interest & Institutional Ownership Analysis

MetricFAELAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i311.26M7.22M
Float Shares i229.08MN/A
% Held by Insiders i20.35%61.15%
% Held by Institutions i15.69%0.49%
% Held by Public i63.96%38.36%

Dividend Analysis & Yield Comparison: Faes Farma S.A. vs Labiana Health S.A.

MetricFAELAB
Last 12-Month Dividend i€0.22N/A
Last 12-Month Dividend Yield i4.09%N/A
3-Year Avg Annual Dividend i€0.17N/A
3-Year Avg Dividend Yield i2.22%N/A
3-Year Total Dividends i€0.50N/A
Ex-Dividend DateJan 08, 2026N/A